MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. Research and Development Expense
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. (MHUAF) reported Research and Development Expense of $2.38 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-29
| Period end | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|
| 2025-12-31 | $2.38M 20-F · filed 2026-04-29 | |
| 2025-06-30 | $1.33M 6-K · filed 2025-09-18 | |
| 2024-12-31 | $3.46M 20-F · filed 2026-04-29 | |
| 2024-06-30 | $1.46M 6-K · filed 2025-09-18 | |
| 2023-12-31 | $2.75M 20-F · filed 2026-04-29 | |
| 2023-06-30 | $1.46M 6-K · filed 2024-09-20 | |
| 2022-12-31 | $2.96M 20-F · filed 2025-04-25 | |
| 2022-06-30 | $1.64M 6-K · filed 2023-10-02 | |
| 2021-12-31 | $2.73M 20-F · filed 2024-04-24 | |
| 2020-12-31 | $2.49M 20-F/A · filed 2023-08-29 | |
| 2019-12-31 | $3.21M 20-F · filed 2022-07-29 |